Use of Molecular Modelling, Docking, and 3D-QSAR Studies for the Determination of the Binding Mode of 3-Benzofuranyl-4-indolyl-maleimides as GSK-3β Inhibitors

Documenti analoghi

• Insights into the interactions between maleimide derivates and GSK3β combining molecular docking and QSAR.
  di: Luisa Quesada-Romero, et al.
  Pubblicazione: (2014-01-01)
• Insights into the Interactions between Maleimide Derivates and GSK3β Combining Molecular Docking and QSAR
  di: Quesada-Romero, Luisa, et al.
  Pubblicazione: (2014)
• From a Natural Product Lead to the Identification of Potent and Selective Benzofuran-3-yl-(indol-3-yl)maleimides as Glycogen Synthase Kinase 3β Inhibitors that Suppress Proliferation and Survival of Pancreatic Cancer Cells
  di: Gaisina, Irina N., et al.
  Pubblicazione: (2009)
• Characterization of Maleimide-Based Glycogen Synthase Kinase-3 (GSK-3) Inhibitors as Stimulators of Steroidogenesis
  di: Gunosewoyo, Hendra, et al.
  Pubblicazione: (2013)
• Identification of a Maleimide-Based Glycogen Synthase Kinase-3 (GSK-3) Inhibitor, BIP-135, That Prolongs the Median Survival Time of Δ7 SMA KO Mouse Model of Spinal Muscular Atrophy
  di: Chen, Po C., et al.
  Pubblicazione: (2011)